VHT ETF Analysis

Esta página fue traducida automáticamente del original en inglés mediante IA; la versión en inglés es la autorizada. Leer la versión en inglés

Solo con fines informativos. No es asesoramiento financiero.

Respuesta Rápida

VHT ETF has a last stored price of $311.90, as of the Oct 2, 2026 trading session. Holdings and weights below are as of Mar 15, 2026.

In the stored portfolio snapshot, the largest listed holding is Eli Lilly and Co (LLY) at 12.70%.

VHT ETF — Price, Holdings & Analysis

Descripción general del ETF

VHT provides targeted exposure to the health care sector. The fund's strategy focuses on large-cap companies, with Eli Lilly and Co (LLY) representing the largest allocation at 12.70%, followed by Johnson & Johnson (JNJ) at 8.22% and AbbVie Inc (ABBV) at 6.00%. This concentrated approach allows investors to gain specific exposure to leading companies within the pharmaceutical, biotechnology, and health care equipment industries. The fund's selection methodology prioritizes established companies with significant market capitalization, potentially offering stability compared to broader health care ETFs. VHT may appeal to investors seeking a focused approach to health care investing, but its concentrated nature warrants careful consideration. Past performance does not guarantee future results.

Métricas de riesgo

VHT's concentrated portfolio introduces a higher level of concentration risk compared to more diversified health care ETFs. The top holding, Eli Lilly and Co (LLY), accounts for 12.70% of the fund, meaning its performance significantly impacts VHT's overall returns. The fund's beta of 0.73 suggests lower volatility compared to the broader market, but the concentrated nature of the holdings could still lead to significant price fluctuations. Investors should also consider the potential impact of regulatory changes and drug pricing pressures on the pharmaceutical and biotechnology industries, which could disproportionately affect VHT due to its sector focus. Past performance does not guarantee future results.

Beta: 0.73

¿Qué contiene VHT?

Participación	Peso
Eli Lilly and Co (LLY)	12.70%
Johnson & Johnson (JNJ)	8.22%
AbbVie Inc (ABBV)	6.00%
Merck & Co Inc (MRK)	4.19%
UnitedHealth Group Inc (UNH)	3.96%
Thermo Fisher Scientific Inc (TMO)	3.33%
Abbott Laboratories (ABT)	2.90%
Amgen Inc (AMGN)	2.80%
Intuitive Surgical Inc (ISRG)	2.75%
Gilead Sciences Inc (GILD)	2.68%

Participaciones y ponderaciones a 15 mar 2026. Estos datos del fondo tienen más de 45 días; verifique las participaciones actuales con el emisor.

Rentabilidad por dividendo

1.03%

Preguntas y respuestas

What is VHT and what does it track?

VHT is an exchange-traded fund (ETF) that provides focused exposure to the health care sector. Unlike broader health care ETFs, VHT holds a very.

The fund's top holdings include companies like Eli Lilly and Co (LLY), Johnson & Johnson (JNJ), and AbbVie Inc (ABBV).

What are the top holdings in VHT?

VHT's top holdings are heavily weighted towards leading companies in the pharmaceutical and health care sectors.

As of 2026-03-15, the top three holdings are Eli Lilly and Co (LLY) at 12.70%, Johnson & Johnson (JNJ) at 8.22%, and AbbVie Inc (ABBV) at 6.00%.

Is VHT a good long-term investment?

Whether VHT is a suitable long-term investment depends on an individual investor's risk tolerance, investment objectives, and time horizon. VHT offers focused exposure to the health care sector through a concentrated portfolio.

The fund's beta of 0.73 suggests lower volatility compared to the broader market, but the concentrated nature of the holdings could still lead to significant price fluctuations.

How does VHT compare to similar ETFs?

VHT distinguishes itself from other health care ETFs through its highly.

While specific expense ratio and AUM data are unavailable, the fund's strategy of focusing on a small number of large-cap companies sets it apart from more diversified health care ETFs. Investors seeking targeted exposure to leading companies within the pharmaceutical and biotechnology industries may find VHT appealing.

Does VHT pay dividends?

Yes, VHT distributes dividends to its shareholders. As of 2026-03-15, VHT has a dividend yield of 1.03%. The dividend yield represents the annual dividend income received from the fund, expressed as a percentage of the fund's net asset value.

Investors seeking income from their investments may find VHT's dividend yield attractive, but it's important to note that dividend yields can fluctuate over time. Past performance does not guarantee future results.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Datos proporcionados solo con fines informativos.

Escrito por una máquina, sin revisión página por página. La supervisión editorial es sistémica: se comprueban las reglas y las fuentes, no cada página.